- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Artiva Biotherapeutics Inc (ARTV)
Artiva Biotherapeutics Inc stock price live, this page displays NASDAQ ARTV stock exchange data. View the ARTV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Artiva Biotherapeutics Inc real time stock price chart below.
What Is the Artiva Biotherapeutics Inc Stock Price Today?
The Artiva Biotherapeutics Inc stock price today is 2.04.
What Is the Stock Symbol for Artiva Biotherapeutics Inc?
The stock symbol for Artiva Biotherapeutics Inc is "ARTV."
What Stock Exchange Does Artiva Biotherapeutics Inc Trade On?
Artiva Biotherapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Artiva Biotherapeutics Inc a Good Stock to Buy?
Determining whether Artiva Biotherapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ARTV quote. (ISIN: US04317A1079)
What Is the Artiva Biotherapeutics Inc Stock Price Today?
The Artiva Biotherapeutics Inc stock price today is 2.04.
What Is the Stock Symbol for Artiva Biotherapeutics Inc?
The stock symbol for Artiva Biotherapeutics Inc is "ARTV."
What Stock Exchange Does Artiva Biotherapeutics Inc Trade On?
Artiva Biotherapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Artiva Biotherapeutics Inc a Good Stock to Buy?
Determining whether Artiva Biotherapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ARTV quote. (ISIN: US04317A1079)
NASDAQ
Currency in USD
2.04
+0.25(+13.97%)
Closed·
After Hours
1.95-0.09(-4.41%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.77
2.07
52 wk Range
1.47
17.31
ARTV Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.772.07
52 wk Range
1.4717.31
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ARTV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
15.40
Upside
+654.90%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Artiva Biotherapeutics Inc Company Profile
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. The company's lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, and B-cell-non-Hodgkin lymphoma. It also develops AB-201, an allogeneic anti- human epidermal growth factor receptor 2 targeting chimeric antigen receptor (CAR)-NK cell product candidate for the treatment of various solid tumors, such as breast, gastric and esophageal, and bladder cancers; and AB-205, an allogeneic anti-CD5 CAR-NK cell product candidate for the treatment of hematological malignancies. Artiva Biotherapeutics, Inc. was incorporated in 2019 and is headquartered in San Diego, California.
Artiva Biotherapeutics Inc SWOT Analysis
NK Cell Innovation | Artiva Biotherapeutics pioneers NK cell therapies for autoimmune diseases, offering a potentially safer alternative to CAR-T treatments with lower manufacturing costs |
Financial Fortitude | With a strong cash position and runway through 2026, Artiva is well-positioned to advance its clinical trials and expand into multiple autoimmune indications |
Market Opportunity | Analyst price targets range from $18 to $23, reflecting optimism about Artiva's potential in the substantial autoimmune disease market |
Competitive Edge | Explore Artiva's scalable manufacturing process and low COGS, which could provide a significant advantage in the crowded immunology market |
Compare ARTV to Peers and Sector
Metrics to compare | ARTV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipARTVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | −0.4x | −0.5x | |
PEG Ratio | −0.01 | 0.01 | 0.00 | |
Price/Book | 0.3x | 1.7x | 2.6x | |
Price / LTM Sales | - | 9.6x | 3.2x | |
Upside (Analyst Target) | - | 106.6% | 45.9% | |
Fair Value Upside | Unlock | 16.4% | 7.0% | Unlock |
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 15.40
(+654.90% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
-0.83 / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Artiva Biotherapeutics (ARTV) Stock Price Today?
The Artiva Biotherapeutics stock price today is 2.04
What Stock Exchange Does Artiva Biotherapeutics Trade On?
Artiva Biotherapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Artiva Biotherapeutics?
The stock symbol for Artiva Biotherapeutics is "ARTV."
What Is the Artiva Biotherapeutics Market Cap?
As of today, Artiva Biotherapeutics market cap is 49.70M.
What Is Artiva Biotherapeutics's Earnings Per Share (TTM)?
The Artiva Biotherapeutics EPS (TTM) is -4.18.
When Is the Next Artiva Biotherapeutics Earnings Date?
Artiva Biotherapeutics will release its next earnings report on 27 Aug 2025.
From a Technical Analysis Perspective, Is ARTV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Artiva Biotherapeutics Stock Split?
Artiva Biotherapeutics has split 0 times.
How Many Employees Does Artiva Biotherapeutics Have?
Artiva Biotherapeutics has 96 employees.
What is the current trading status of Artiva Biotherapeutics (ARTV)?
As of 13 July 2025, Artiva Biotherapeutics (ARTV) is trading at a price of 2.04, with a previous close of 2.04. The stock has fluctuated within a day range of 1.77 to 2.07, while its 52-week range spans from 1.47 to 17.31.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.